Cardio Diagnostics Partners with Aimil and Dr. Lal PathLabs to Launch PrecisionCHD Test in India.
ByAinvest
Wednesday, Jan 7, 2026 6:28 am ET1min read
CDIO--
Cardio Diagnostics, Aimil Ltd., and Dr. Lal PathLabs have partnered to launch the PrecisionCHD test for coronary heart disease detection in India. PrecisionCHD combines epigenetics and AI to detect CHD at a molecular level, providing actionable insights for personalized treatment and management. The partnership marks Cardio Diagnostics' first expansion outside the US and aims to make advanced cardiovascular diagnostics accessible in India, where cardiovascular disease remains a leading health concern.
Stay ahead of the market.
Get curated U.S. market news, insights and key dates delivered to your inbox.
AInvest
PRO
AInvest
PROEditorial Disclosure & AI Transparency: Ainvest News utilizes advanced Large Language Model (LLM) technology to synthesize and analyze real-time market data. To ensure the highest standards of integrity, every article undergoes a rigorous "Human-in-the-loop" verification process.
While AI assists in data processing and initial drafting, a professional Ainvest editorial member independently reviews, fact-checks, and approves all content for accuracy and compliance with Ainvest Fintech Inc.’s editorial standards. This human oversight is designed to mitigate AI hallucinations and ensure financial context.
Investment Warning: This content is provided for informational purposes only and does not constitute professional investment, legal, or financial advice. Markets involve inherent risks. Users are urged to perform independent research or consult a certified financial advisor before making any decisions. Ainvest Fintech Inc. disclaims all liability for actions taken based on this information. Found an error?Report an Issue
Comments
No comments yet